ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers

被引：1
|
作者：
Dee, Edward Christopher [1 ]
Freret, Morgan E. [2 ]
Wo, Jennifer Y. [1 ,3 ]
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / 13期
关键词：
GEMCITABINE; CHOLANGIOCARCINOMA; CHEMOTHERAPY; TRIAL;
D O I：
10.1245/s10434-020-08970-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5173 / 5174
页数：2
相关论文
共 50 条
  • [1] ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers
    Edward Christopher Dee
    Morgan E. Freret
    Jennifer Y. Wo
    Annals of Surgical Oncology, 2020, 27 : 5173 - 5174
  • [2] ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications
    Dominguez, Dana A.
    Melstrom, Laleh G.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 4942 - 4943
  • [3] ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers—Does One Size Fit All?
    Kristen E. Rhodin
    Michael E. Lidsky
    Annals of Surgical Oncology, 2023, 30 : 4822 - 4823
  • [4] ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers-Does One Size Fit All?
    Rhodin, Kristen E.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (08) : 4822 - 4823
  • [5] Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor
    Edward Christopher Dee
    Morgan E. Freret
    Jennifer Y. Wo
    Annals of Surgical Oncology, 2020, 27 : 937 - 939
  • [6] Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor
    Dee, Edward Christopher
    Freret, Morgan E.
    Wo, Jennifer Y.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 937 - 939
  • [7] Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?
    Ma, Wen-Jie
    Zhou, Rong-Xing
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 934 - 936
  • [8] Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?
    Wen-Jie Ma
    Rong-Xing Zhou
    Annals of Surgical Oncology, 2020, 27 : 934 - 936
  • [9] ASO Visual Abstract: Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers
    Kristen E. Rhodin
    Annie Liu
    Alex Bartholomew
    Ryan Kramer
    Anika Parameswaran
    Hope Uronis
    John Strickler
    David Hsu
    Michael A. Morse
    Kevin N. Shah
    Garth Herbert
    Sabino Zani
    Daniel P. Nussbaum
    Peter J. Allen
    Michael E. Lidsky
    Annals of Surgical Oncology, 2023, 30 : 4824 - 4825
  • [10] Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
    Shulman, Rebecca M.
    Meyer, Joshua E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 4867 - 4869
12345